LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation

Cell

Volumn 71, Issue 3, 1992, Pages 411-421

  Herz, Joachim ^a   Clouthier, David E ^a   Hammer, Robert E ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR PROTEIN; UROKINASE;

ANIMAL CELL; ARTICLE; BLASTOCYST; COMPLEX FORMATION; CONTROLLED STUDY; GENE LOCUS; GENE TARGETING; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; MOUSE; NIDATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMAL; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; EMBRYO IMPLANTATION; ENDOCYTOSIS; FEMALE; LDL-RECEPTOR RELATED PROTEIN 1; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, IMMUNOLOGIC; STEM CELLS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TROPHOBLASTS; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA;

EID: 0026439778     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90511-A     Document Type: Article

References (55)

1. The receptor-binding sequence of urokinase
2. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths
3. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein
4. Production and analysis of chimeric mice
5. The low-density lipoprotein receptor-related protein: double agent or decoy?
6. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome
7. 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator (t-PA)
8. Altering the genome by homologous recombination
9. NPXY, a sequence often found in cytoplasmic tails, is required for coated pitmediated internalization of the low density lipoprotein receptor
10. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAl-1
11. Report of the comparative subcommittee for human and mouse homologies
12. Giant cell differentiation and lethality of homozygous yellow mouse embryos
13. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
14. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril
15. Familial hypercholesterolemia
16. Receptormediated endocytosis of LDL in cultured cells
17. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants
18. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor
19. Proteolytic processing of the 600 kD low density lipoprotein receptor related protein (LRP) occurs in a trans-Golgi compartment
20. Low density lipoprotein receptor-related protein mediates endocytosis of monoclonal antibodies in cultured cells and rabbit liver
21. 2-macroglobulin receptor
22. 2-macroglobulin receptor to mouse chromosome 15 and to human chromosome 12q13-q14 by isotopic and nonisotopic in situ hybridization
23. 2-macroglobulin and pregnancy zone protein-proteinase complexes in the human placental syncytiotrophoblast
24. Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells
25. Recombinant fragment assay for gene targeting based on the polymerase chain reaction
26. Low density lipoprotein-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins
27. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein
28. 2-macroglobulin receptor
29. Protein measurement with the folin phenol reagent
30. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
31. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes
32. The Wnt-1 (int-1) protooncogene is required for development of a large region of the mouse brain
33. 2-macroglobulin receptor (low density lipoprotein receptor-related protein)
34. The gene for the human putative apo E receptor is on chromosome 12 in the segment q13–14
35. 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes
36. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor
37. 2-macroglobulin receptor
38. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase
39. In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion
40. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
41. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator
42. Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation
43. Embryo-derived stem cell lines
44. Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor
45. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos
46. Familial apolipoprotein E deficiency
47. Apolipoprotein expression by murine visceral yolk sac endoderm
48. Autocrine saturation of pro-urokinase receptors on human A431 cells
49. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor
50. 2-macroglobulin receptor-associated protein
51. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm
52. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
53. Purification of an inhibitor of plasminogen activator (anti-activator) synthesized by endothelial cells
54. Gene targeting in normal and amplified cell lines